Best Biopharma Outsourcing Companies in Ohio, United States
The 41 best Biopharma Outsourcing companies in Ohio, United States in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: AmplifyBio.
Our analysis of 50 Biopharma Outsourcing companies
$6.3b in tracked funding; 77% of the stack-profiled cohort runs cloud-native; funding activity peaked in 2025.
Ranked: Best Biopharma Outsourcing companies in Ohio
| # | Company | Disclosed funding | Last round | Stage | Founder | Founded | Tech stack | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|---|
| 1 | AmplifyBio Provider of contract research, development, and manufacturing services for biologic drugs | $230M | 34 mo ago | Deadpooled | Kelly Ganjei President & Chief Executive Officer | 2021 | WordPressMySQLPHP+17 | — | — |
| 2 | RXQ Compounding Pharmaceutical products manufacturing unit | $4M | 96 mo ago | Deadpooled | Edward Zatta Founder & President | 2014 | — | — | — |
| 3 | DNA Nanobots Biotech company that uses nanotechnology to deliver targeted chemotherapy, vaccines, and gene therapy 19Talent top 38%Funding bottom 44%Global bottom 25%Tech bottom 18% All 4 signals ▾Talenttop 38% Fundingbottom 44% Globalbottom 25% Techbottom 18% Talent: 2 named leaders on record · 2 C-suite/founder profiles curated Funding: Raised $3.5M across 1 rounds · 1 rounds over 2 yrs (0.5/yr) rank vs industry peers · Fliar Intelligence Index 19/100 | $4M | 8 mo ago | Seed | Melika Shahhosseini Co-Founder | 2021 | PHPMediaElement.jsApache HTTP Server+9 | — | — |
| 4 | Renovo Neural Provider of preclinical services oferring assays/models in neurodegenerative diseases | $605K | 167 mo ago | Funding Raised | — | 2008 | — | — | — |
| 5 | Better For You Wellness CDMO focused on manufacturing of plant based drugs | $28K | 24 mo ago | Funding Raised | Ian James CEO and Chairman | 2011 | — | — | — |
| 6 | OncoSolutions 3D tumor model for rapid screening of oncology drugs | $25K | 107 mo ago | Deadpooled | Stephanie Ham CEO & Co-Founder | 2016 | — | — | — |
| 7 | bTECH Provider of regulatory strategy development services for biopharma sector | $20K | 29 mo ago | Seed | Wendy Slone Founder & CEO | 2016 | — | 39 patents AI-driven battery health monitoring and electrolyte level sensing for advanced BMS | — |
| 8 | Relevate Health Group Provider of marketing services to biopharma sector | — | 68 mo ago | Funding Raised | — | 2015 | — | — | — |
Top 12 Biopharma Outsourcing companies in Ohio
#1
Seed · Powell, Ohio · founded 2021$3.5Mraised▾
DNA Nanobots is a biotech company that uses nanotechnology to deliver targeted chemotherapy, vaccines, and gene therapy. They have developed a revolutionary technology for fast and reliable delivery. The company has closed a pre-seed investment round to grow their biopharma partner program.
- Dec 2025Seed$3.5M
- Jan 2024Seed—
#2
Deadpooled · Hilliard, Ohio · founded 2021 · 228 employees$229.8Mraised▾
Provider of contract research, development, and manufacturing services for biologic drugs
- Oct 2023Series C$49.8M
- Jan 2023Venture Debt—
- Apr 2022Series C$100M
- May 2021Series C$80M
#3
Deadpooled · Athens, Ohio · founded 2014 · 20 employees$3.6Mraised▾
RXQ Compounding is a pharmaceutical products manufacturing unit. They offer both sterile and non-sterile production units (creams, ointments, tablets, and liquids) for manufacturing of pharmaceutical products. The company has FDA 503B outsourcing facility.
- Aug 2018Series A$3.6M
#4
Funding Raised · Columbus, Ohio · founded 2011 · 2 employees$28Kraised▾
CDMO focused on manufacturing of plant based drugs
- Aug 2024Conventional Debt$28K
#5
Seed · Cleveland, Ohio · founded 2016$20Kraised▾
Provider of regulatory strategy development services for biopharma sector
#6
Funding Raised · Cleveland, Ohio · founded 2008 · 16 employees$605Kraised▾
Renovo Neural is a specialized preclinical research organization offering model systems and automated electron microscopy applications to provide standard and customizable solutions for basic science, preclinical, and clinical research to pharmaceutical and biotechnology companies, non-profit organizations, and academic researchers. They specialize in the development of reliable and reproducible preclinical assays/models in neurodegenerative disease, including Multiple Sclerosis, Alzheimer’s Disease, and Parkinson’s Disease.
- Sep 2012Grant (prize money)$605K
#7
Deadpooled · Akron, Ohio · founded 2016 · 3 employees$25Kraised▾
OncoSolutions claims to have developed a high-throughput 3D tumor model (which according to company claims is also the first 3D engineered tumor model) for rapid screening of oncology drugs in the preclinical phase. The company is developing 3D tumor model (patented) in the microplate using a robotic platform and aqueous polymeric system. The company was awarded a Technology Validation and Start-up Fund (TVSF) grant from Ohio Third Frontier in March 2017.
- Sep 2017Grant (prize money)$25K
#8
Funding Raised · Cincinnati, Ohio · founded 2015 · 107 employees—raised▾
Provider of marketing services to biopharma sector
- Dec 2020Conventional Debt—
#9
Acquired · Cincinnati, Ohio · founded 1997 · 110 employees—raised▾
Provider of supply chain logistics services for biopharma sector
#10
Acquired · Powell, Ohio · founded 2003 · 168 employees—raised▾
Provider of market intelligence and commercialization services
- Jan 2017Series A—
#11
Late Stage · Cincinnati, Ohio · founded 1983 · 107 employees—raised▾
Streamlining research with comprehensive IRB, IBC, and data management solutions. The company offers a suite of services focused on enhancing research efficiency and ensuring ethical compliance. These include Institutional Review Board (IRB) services, Institutional Biosafety Committee (IBC) oversight, Data Monitoring Committee (DMC) support, and Endpoint Adjudication Committee (EAC) facilitation. The company provides technology solutions like Clinical Trial Management Systems (CTMS), eSource + EDC platforms, and eRegulatory Management tools. They offer solutions for sponsors, CROs, and research sites, encompassing study design, startup, enrollment management, and GxP services. The company leverages technology and AI through platforms like Braid™ to improve operational intelligence and automation in clinical trials. They offer safety and ethics review, site enablement services, clinical research staffing, training, and compliance support. The company aims to improve human subject protections and compliant study conduct with reliable services and extensive therapeutic expertise. They also offer a login portal, community forum, and resource library.
- Dec 2014PE—
#12
Acquired · Cleveland, Ohio · founded 1998 · 51 employees—raised▾
Provider of ion channel testing services. The company provides validated assays to test ion channels for pharmaceutical and biotech industries. It also provides functional screens for profiling drug candidates and ranking profiles during drug discovery processes.
Funding & investor landscape
Notable founders
Market landscape — 10 sub-themes by coverage
Share of Biopharma Outsourcing coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising
How research on Biotechnology in Ohio is moving
A read on the academic research around Biotechnology in Ohio — which themes are gaining ground, the institutions and researchers driving them, and how the tone is shifting. Based on 72 papers.
- The Ohio State University62
- The Ohio State University Wexner Medical Center8
- Ohio University6
- The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute4
- Northeast Ohio Medical University2
- microRNA5
- Gene silencing4
- Cancer research4
- Gene expression3
- Gene3
- In vivo3
- microRNA2
- Ex vivo2
- Cancer research2
- Antimicrobial2
- Antibiotics2
- Microbiome2
- Rumen2
- Dairy cattle2
- Biological pest control1
Common questions
Rohit lives in the feed. He covers what's moving right now — the funding rounds, launches and shifts breaking across the trade press — and ties them back to where the sector is heading.